Related Articles
Hypertrophic differentiation of mesenchymal stem cells is suppressed by xanthotoxin via the p38‑MAPK/HDAC4 pathway
Adenovirus-mediated bone morphogenetic protein-2 promotes osteogenic differentiation in human mesenchymal stem cells in vitro
Experimental chondrocyte hypertrophy is promoted by the activation of discoidin domain receptor 2
Icariin promotes stable chondrogenic differentiation of bone marrow mesenchymal stem cells in self‑assembling peptide nanofiber hydrogel scaffolds
Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro